Salt IP - Search Results

1

AMPK-friend or foe for targeted therapy?

Choudhury Y, Salt IP, Leung HY. Choudhury Y, et al. Among authors: salt ip. Cell Cycle. 2015;14(12):1761-2. doi: 10.1080/15384101.2015.1022066. Cell Cycle. 2015. PMID: 26036305 Free PMC article. No abstract available.

2

AMP-activated protein kinase (AMPK) as a potential therapeutic target independent of PI3K/Akt signaling in prostate cancer.

Choudhury Y, Yang Z, Ahmad I, Nixon C, Salt IP, Leung HY. Choudhury Y, et al. Among authors: salt ip. Oncoscience. 2014 Jun 4;1(6):446-56. doi: 10.18632/oncoscience.49. eCollection 2014. Oncoscience. 2014. PMID: 25594043 Free PMC article.

3

Investigating the Role of AMPK in Inflammation.

Mancini SJ, Salt IP. Mancini SJ, et al. Among authors: salt ip. Methods Mol Biol. 2018;1732:307-319. doi: 10.1007/978-1-4939-7598-3_20. Methods Mol Biol. 2018. PMID: 29480484

4

The role of AMP-activated protein kinase in the functional effects of vascular endothelial growth factor-A and -B in human aortic endothelial cells.

Reihill JA, Ewart MA, Salt IP. Reihill JA, et al. Among authors: salt ip. Vasc Cell. 2011 Apr 20;3:9. doi: 10.1186/2045-824X-3-9. Vasc Cell. 2011. PMID: 21507243 Free PMC article.

5

Metformin Reverses Development of Pulmonary Hypertension via Aromatase Inhibition.

Dean A, Nilsen M, Loughlin L, Salt IP, MacLean MR. Dean A, et al. Among authors: salt ip. Hypertension. 2016 Aug;68(2):446-54. doi: 10.1161/HYPERTENSIONAHA.116.07353. Epub 2016 Jun 13. Hypertension. 2016. PMID: 27296990 Free article.

6

The Na+/Glucose Cotransporter Inhibitor Canagliflozin Activates AMPK by Inhibiting Mitochondrial Function and Increasing Cellular AMP Levels.

Hawley SA, Ford RJ, Smith BK, Gowans GJ, Mancini SJ, Pitt RD, Day EA, Salt IP, Steinberg GR, Hardie DG. Hawley SA, et al. Among authors: salt ip. Diabetes. 2016 Sep;65(9):2784-94. doi: 10.2337/db16-0058. Epub 2016 Jul 5. Diabetes. 2016. PMID: 27381369 Free PMC article.

7

Metformin suppresses adipogenesis through both AMP-activated protein kinase (AMPK)-dependent and AMPK-independent mechanisms.

Chen SC, Brooks R, Houskeeper J, Bremner SK, Dunlop J, Viollet B, Logan PJ, Salt IP, Ahmed SF, Yarwood SJ. Chen SC, et al. Among authors: salt ip. Mol Cell Endocrinol. 2017 Jan 15;440:57-68. doi: 10.1016/j.mce.2016.11.011. Epub 2016 Nov 14. Mol Cell Endocrinol. 2017. PMID: 27856330 Free PMC article.

8

Phosphorylation of Janus kinase 1 (JAK1) by AMP-activated protein kinase (AMPK) links energy sensing to anti-inflammatory signaling.

Rutherford C, Speirs C, Williams JJ, Ewart MA, Mancini SJ, Hawley SA, Delles C, Viollet B, Costa-Pereira AP, Baillie GS, Salt IP, Palmer TM. Rutherford C, et al. Among authors: salt ip. Sci Signal. 2016 Nov 8;9(453):ra109. doi: 10.1126/scisignal.aaf8566. Sci Signal. 2016. PMID: 27919027 Free article.

9

Corrigendum to "Metformin suppresses adipogenesis through both AMP-activated protein kinase (AMPK)-dependent and AMPK-independent mechanisms" [Mol. Cell. Endocrinol. 440 15 January 2017 57-68].

Chen SC, Brooks R, Houskeeper J, Bremner SK, Dunlop J, Viollet B, Logan PJ, Salt IP, Ahmed SF, Yarwood SJ. Chen SC, et al. Among authors: salt ip. Mol Cell Endocrinol. 2017 Mar 5;443:176. doi: 10.1016/j.mce.2017.01.049. Mol Cell Endocrinol. 2017. PMID: 28183460 Free PMC article. No abstract available.

10

Linking energy sensing to suppression of JAK-STAT signalling: A potential route for repurposing AMPK activators?

Speirs C, Williams JJL, Riches K, Salt IP, Palmer TM. Speirs C, et al. Among authors: salt ip. Pharmacol Res. 2018 Feb;128:88-100. doi: 10.1016/j.phrs.2017.10.001. Epub 2017 Oct 13. Pharmacol Res. 2018. PMID: 29037480 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

58 results

Search Page